Zdrowie i gospodarka · 17/08/2011

FDA Reorganizes CDER into Four New Divisions under Office of Generic Drugs

The Food and Drug Administration (FDA) has reorganized the Center for Drug Evaluation and Research (CDER) by establishing four new Divisions under the Office of Generic Drugs, as outlined in the Staff Manual Guide. This reorganization aims to improve the efficiency and effectiveness of the CDER's operations.